PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
Volume 8 Issue 2

TPDs: Developing the Next Generation of Oral Therapeutics

Targeted Protein Degraders (TPDs) are transforming the landscape of modern drug discovery and development, introducing a ground-breaking method for tackling diseases...
Continue Reading →
Volume 8 Issue 2

Harnessing the Power of Generative AI: Transforming Life Science Manufacturing

The life science industry faces the challenges of developing and delivering life-changing medicines at an accelerated pace, all while maintaining quality and safety ...
Continue Reading →
Volume 8 Issue 2

Building a Global Data Foundation for Scaling AI 

AI use cases are rippling across commercial biopharma, helping companies make faster, more informed decisions. Yet almost 70% of top generative AI (GenAI) users cite...
Continue Reading →
Volume 8 Issue 2

Regulatory Impact Assessment is Obvious Next Target for GenAI, Experts Conclude 

When anything changes to a product’s make-up or manufacture, a whole chain of events is triggered, starting with an assessment of the regulatory impact in each regul...
Continue Reading →
Volume 8 Issue 2

Avoiding the Domino Effect: How Smarter Temperature Control and Excursion Management Prevent Clinical Trial Disruptions 

When investigational medicinal products (IMPs) are exposed to conditions outside of their approved storage range, sponsors need to be ready to act or risk the integr...
Continue Reading →
Volume 8 Issue 1

Interview with CEO Dr. Chris Chen of WuXi Biologics

Quality Assurance Evolution in the Biopharmaceutical CDMO Industry – stricter regulations, technological advancements, risk management, globalisation and client expe...
Continue Reading →
Volume 8 Issue 1

IDMP Readiness & FAIR Data Adoption: Where are Life Science Organisations Now?

Pharma companies remain at differing levels of readiness for implementing ISO IDMP product data standards, and in their maturity around adopting FAIR data principles...
Continue Reading →
Volume 8 Issue 1

Transgene Expression Methods for Viral Vector Therapeutics: A Critical Component in Drug Development

Viral vector-based therapeutics have revolutionised modern medicine, enabling precise gene delivery for treating genetic disorders, cancers, and infectious diseases....
Continue Reading →
Volume 8 Issue 1

Advances in RNA Vaccine Development and Delivery: A Multifaceted Approach to Infectious Diseases and Cancer

The emergence of RNA vaccines against SARS-CoV-2 has revolutionised the biomedical field, offering unprecedented flexibility, precision, and scalability in therapeut...
Continue Reading →
Volume 8 Issue 1

The Ins and Outs About Getting to the Most Relevant 3D In Vitro Model: Facts, Trends and Expectations

“What we believe in, is putting the best biology we can into our models to mimic human biology”. In recent years, there have been significant advances in technolo...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC